Safety, Immunogenicity and Pharmacokinetics of SYN004 in Patients With Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Colon Cancer, Breast Cancer, Cancer of the Head and Neck
Interventions: BIOLOGICAL: SYN004
Sponsor: Synermore Biologics Co., Ltd.